Following ectodomain cleavage of the amyloid precursor protein (APP) [3] by β-secretase, γ-secretase cleavage releases the amyloid beta peptide (Aβ) that accumulates in the brains of patients with Alzheimer's disease (AD) [4]. Here, APP is linked to Alzheimer disease.